The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 828.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.24%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 828.00
MAB1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

24 May 2023 07:00

RNS Number : 4155A
Mortgage Advice Bureau (Hldgs) PLC
24 May 2023
 

24 May 2023

Mortgage Advice Bureau (Holdings) plc ("MAB" or "the Group")

AGM Statement

Mortgage Advice Bureau (Holdings) plc (AIM:MAB1.L) will hold its Annual General Meeting at 2pm today during which the Non-Executive Chair, Katherine Innes Ker, will make the following statement:

"In an ongoing challenging environment, we continue to demonstrate the strength of MAB's model and resilience in adviser numbers and mortgage completions against a significantly weaker market backdrop. This positions the Group well for subsequent market recovery.

"Our Adviser numbers have stabilised in Q2 at 2,1221 advisers on 19 May 2023. We expect our existing Appointed Representative firms to start growing their adviser numbers again later in the year, most likely as consumer confidence improves further when there is more certainty around the outlook for mortgage interest rates and our firms can plan with a greater degree of certainty. Our pipeline of incoming new Appointed Representatives has grown strongly this year.

"As expected, the value of completions in the wider market was slower in Q1 2023 with a 21% reduction in new mortgage lending2 compared to last year. MAB's total mortgage completions for Q1 2023 were broadly stable at £5.8bn (2022: £5.9bn). Our new mortgage completions were £4.4bn (2022: £4.9bn) with the balance of £1.4bn (2022: £1.0bn) being Product Transfers. We have continued to grow our market share, which has been achieved despite a reduction in the number of advisers since Q4 2022.

"During the six months following the mini-budget, new mortgage approvals across the market were down by as much as 40% versus the prior year. There are early signs of increasing activity and mortgage approval levels have now gradually started to improve, but remain significantly lower than for the equivalent period last year.

"MAB's performance, despite challenging market conditions, remains in line with the Board's expectations with further improvement expected in the second-half of the year."

 

1 Includes 139 Fluent advisers as at 19 May 2023 (76 advisers in the first charge mortgages division, 49 in the secured personal loans division, 8 in the later life division, and 6 in the bridging finance division). Includes a total of 183 advisers at 19 May 2023 who are later life advisers or advisers in directly authorised firms that use MAB's subsidiary, Auxilium, a specialist protection service provider, for protection. For both later life and directly authorised advisers the fees received by MAB represent the net income received by MAB as there are no commission payouts made by MAB.

2 UK Finance, product transfer lending figures not available until 7 June.

 

Enquiries:

Mortgage Advice Bureau (Holdings) Plc

Tel: +44 (0) 1332 525007

 

Peter Brodnicki - Chief Executive Officer

Ben Thompson - Deputy Chief Executive Officer

Lucy Tilley - Chief Financial Officer

 

Nominated Adviser and Joint Broker:

Numis Securities Limited

Stephen Westgate / Giles Rolls

 

+44 (0)20 7260 1000

Joint Broker:

Peel Hunt LLP

Andrew Buchanan / Mike Burke

 

+44 (0) 20 7418 8900

Media Enquiries: investor.relations@mab.org.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSEDFWDEDSEEI
Date   Source Headline
28th Feb 202010:04 amRNSDirector/PDMR Shareholding
26th Feb 20204:41 pmRNSSecond Price Monitoring Extn
26th Feb 20204:35 pmRNSPrice Monitoring Extension
17th Feb 202010:34 amRNSDirector/PDMR Shareholding
3rd Feb 20204:40 pmRNSSecond Price Monitoring Extn
3rd Feb 20204:35 pmRNSPrice Monitoring Extension
3rd Feb 20202:13 pmRNSHolding(s) in Company
31st Jan 202012:23 pmRNSDirector/PDMR Shareholding
28th Jan 20207:00 amRNSTrading Update
14th Jan 20205:46 pmRNSDirector/PDMR Shareholding
31st Dec 20199:23 amRNSDirector/PDMR Shareholding
16th Dec 20194:13 pmRNSDirector/PDMR Shareholding
12th Dec 201910:18 amRNSBlock listing Interim Review
2nd Dec 20197:00 amRNSDirector/PDMR Shareholding
14th Nov 20193:05 pmRNSDirector/PDMR Shareholding
31st Oct 201912:34 pmRNSDirector/PDMR Shareholding
25th Oct 20194:02 pmRNSDirector/PDMR Shareholding
22nd Oct 20195:13 pmRNSHolding(s) in Company
22nd Oct 20195:09 pmRNSHolding(s) in Company
14th Oct 20194:31 pmRNSDirector/PDMR Shareholding
30th Sep 20193:18 pmRNSHolding(s) in Company
30th Sep 20193:13 pmRNSDirector/PDMR Shareholding
24th Sep 20197:00 amRNSHalf-year Report
17th Sep 20196:25 pmRNSDirector/PDMR Shareholding
30th Aug 20192:22 pmRNSDirector/PDMR Shareholding
29th Aug 201912:07 pmRNSSecond Price Monitoring Extn
29th Aug 201912:02 pmRNSPrice Monitoring Extension
27th Aug 201912:07 pmRNSSecond Price Monitoring Extn
27th Aug 201912:02 pmRNSPrice Monitoring Extension
23rd Aug 201912:07 pmRNSSecond Price Monitoring Extn
23rd Aug 201912:02 pmRNSPrice Monitoring Extension
22nd Aug 201912:07 pmRNSSecond Price Monitoring Extn
22nd Aug 201912:02 pmRNSPrice Monitoring Extension
21st Aug 201912:07 pmRNSSecond Price Monitoring Extn
21st Aug 201912:02 pmRNSPrice Monitoring Extension
20th Aug 201912:07 pmRNSSecond Price Monitoring Extn
20th Aug 201912:02 pmRNSPrice Monitoring Extension
19th Aug 201912:07 pmRNSSecond Price Monitoring Extn
19th Aug 201912:02 pmRNSPrice Monitoring Extension
14th Aug 20194:07 pmRNSDirector/PDMR Shareholding
13th Aug 201912:07 pmRNSSecond Price Monitoring Extn
13th Aug 201912:02 pmRNSPrice Monitoring Extension
7th Aug 20199:06 amRNSReplacement: Director/PDMR Shareholding
31st Jul 20195:46 pmRNSDirector/PDMR Shareholding
31st Jul 201912:07 pmRNSSecond Price Monitoring Extn
31st Jul 201912:02 pmRNSPrice Monitoring Extension
29th Jul 201912:07 pmRNSSecond Price Monitoring Extn
29th Jul 201912:02 pmRNSPrice Monitoring Extension
26th Jul 201912:07 pmRNSSecond Price Monitoring Extn
26th Jul 201912:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.